Effect of Anti-diabetic Drugs on Glycemic Variability. A Comparison Between Gliclazide MR (Modified Release) and Dapagliflozin on Glycemic Variability Measured by Continuous Glucose Monitoring (CGM) in Patients With Uncontrolled Type 2 Diabetes
Latest Information Update: 21 Jul 2021
At a glance
- Drugs Dapagliflozin (Primary) ; Gliclazide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms EFFORT
- 01 Mar 2020 Status changed from not yet recruiting to completed.
- 11 Jun 2019 Results presented at the 79th Annual Scientific Sessions of the American Diabetes Association
- 12 Oct 2016 New trial record